Cancer Moonshot℠ - Obligations by Budget Mechanism
With over $175 million obligated for Cancer Moonshot activities in fiscal year (FY) 2022, funding was allocated into four budget mechanisms: research grants, R&D contracts, intramural research, and research management and support, as shown in the chart below.
Similar to the institute’s annual appropriation, NCI reports Cancer Moonshot obligations by funding mechanism.
| Type of Mechanism | Mechanism | Number | Amount1 |
|---|---|---|---|
| Research Project Grants (RPGs) | Competing | 14 | $5,693,666 |
| Noncompeting | 45 | $41,379,489 | |
| Administrative Supplements | 9 | $2,158,670 | |
| Subtotal, without SBIR | 47 | $41,249,931 | |
| SBIR/STTR Grants | 2 | $836,883 | |
| Subtotal, RPGs | 61 | $50,068,708 | |
| Centers | Cancer Centers Grants-P30s | 3 | $4,215,400 |
| P50s | 11 | $13,142,813 | |
| Cooperative Agreements-U54s/U41s | 17 | $11,528,485 | |
| Subtotal, Centers | 32 | $28,886,698 | |
| Other Research | Resource Grants-U24s/U2Cs | 13 |
$33,676,934 |
| Subtotal, Other Research | 13 |
$33,676,934 |
|
| Subtotal, Research Grants | 84 |
$112,632,340 |
|
| Intramural Research | Program | 0 |
$8,454,634 |
| Research Management & Support | RMS | 0 |
$317,353 |
| R&D Contracts | R&D Contracts | 14 |
$50,119,630 |
| SBIR/STTR Contracts | 3 |
$5,951,171 |
|
| Subtotal, R&D Contracts | 17 |
$56,070,801 |
|
| Total |
$177,475,128 |
||
|
1 Includes new obligations and recoveries from fiscal years 2017, 2018, 2019, 2020, and 2021 carryover accounts. |
|||